Sailesh Kotecha on Prematurity-associated lung disease
Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life.Cick here to read the full series: Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypeshttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00372-8/fulltextTrajectories of prematurity-associated lung disease: lifelong lung healthhttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00371-6/fulltextManagement of prematurity-associated lung disease from infancy through to adulthoodhttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00369-8/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
--------
11:29
--------
11:29
Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations
Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations.click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00362-5/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
--------
15:25
--------
15:25
Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change
Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis.Click here to read the full articleContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
--------
10:50
--------
10:50
Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis.Read the full article:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00239-5/fulltext?dgcid=buzzsprout_icw_podcast_September_25_lanresContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
--------
9:26
--------
9:26
Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma
Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS in Amsterdam. The Series aims to provide an overview of recent research advances related to asthma; to provide new insights into the genetics, prevention and risk factors for asthma; review advances arising as a result of the use of monoclonal antibody therapeutics; and assess remission in adult patients. Late breaking research will also be included within the journal session and linked to the Series.Read the full Series:https://www.thelancet.com/series-do/asthma-2025?dgcid=buzzsprout_icw_podcast_asthma25_lanresContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Sobre The Lancet Respiratory Medicine in conversation with
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
Ouça The Lancet Respiratory Medicine in conversation with, Descobri depois de adulta e muitos outros podcasts de todo o mundo com o aplicativo o radio.net